Reading this on a mobile device? Try our optimized mobile version here:

January 9, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • Growth in spending on Rx drugs relatively low
    Medicare and Medicaid payments accounted for nearly one-third of total retail prescription drug spending in 2011, and Medicare is the fastest-growing payer, according to CMS data. Nonetheless, growth in prescription drug spending was lower than spending growth in other areas of health care. Factors including generic substitution kept the share of expenditures attributed to consumers' out-of-pocket costs at an all-time low. Drug Channels (1/8) LinkedInFacebookTwitterEmail this Story
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!

  Legislative & Regulatory News 
  • Self-employed, unemployed struggle to afford health care
    Self-employed, unemployed and other Americans without employer-sponsored health insurance may struggle to find affordable health care while waiting for insurance exchanges to begin enrollment. Some are going without insurance, some are returning to college, and others are turning to religion-affiliated or other cost-sharing plans. Reuters (1/8) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Teva aims to become leader in therapies for women
    Generic-drug-maker Teva Pharmaceutical Industries plans to expand beyond contraception and fertility drugs to other women's health products, such as drugs to treat noncancerous uterine tumors. "It's a huge opportunity," said CEO Jeremy Levin. "Women are great consumers of medicines. They understand what it is that they need to make themselves happier and healthier." Bloomberg (1/8) LinkedInFacebookTwitterEmail this Story
  • FDA approves Wockhardt's generic epilepsy drug
    Wockhardt has received federal approval for its extended-release lamotrigine tablets for the treatment of epilepsy, in strengths of 25 mg, 50 mg, 100 mg, 200 mg and 300 mg. The drug is the generic form of GlaxoSmithKline's Lamictal XR. The Hindu (India) (1/8) LinkedInFacebookTwitterEmail this Story
If you want to test your memory, try to recall what you were worrying about one year ago today."
--E. Joseph Cossman,
American entrepreneur and inventor


Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information